HM1.24-utilizing cancer vaccines
Filed: October 30th, 2003 [Pending]
Patent Application Number: 10533104
The invention also provides a cancer vaccine containing as an active ingredient an HM1 .24 protein or peptide itself. Furthermore, the invention provides a ...
Cancer vaccines containing epitopes of oncofetal antigen
Filed: August 4th, 2003 [Pending]
Patent Application Number: 10523277
... US 20060165709A1 (54) CANCER VACCINES CONTAINING EPITOPES OF ONCOFETAL ANTIGEN (75) Inventors: Joseph H Coggin JR., Mobile, AL (US); James W. Rohrer, ...
Cancer vaccines containing epitopes of oncofetal antigen
Filed: August 5th, 2009 [Pending]
Patent Application Number: 12462514
22, 2010 (54) CANCER VACCINES CONTAINING Related US Application Data EPITOPES OF ONCOFETAL ANTIGEN (63) Continuation of application No.
Cancer vaccines containing xenogeneic epitopes of telomerase reverse ...
Filed: June 24th, 2003 [Pending]
Patent Application Number: 10602441
6440735 describes dendritic cell vaccines containing telomerase reverse transcriptase (TERT) for the treatment of cancer. The antigen-presenting cells ...
GLOBO H AND RELATED ANTI-CANCER VACCINES WITH NOVEL GLYCOLIPID ADJUVANTS
Filed: August 6th, 2009 [Pending]
Patent Application Number: 12537129
More particularly, the invention is directed at anti-cancer Globo H-DT vaccines administered with novel glycolipid adjuvants, such as C34.
Cancer vaccine containing cancer antigen based on tumor suppressor gene wt1 ...
Filed: June 28th, 2002 [Pending]
Patent Application Number: 10482327
EXAMPLES [0028] The usefulness of the cancer vaccine of the present invention will now be explained with reference to Examples. Example 1 Preparation of ...
Cancer Stem Cell Vaccine
Filed: February 24th, 2010 [Pending]
Patent Application Number: 12711699
These requirements include the following which are required for a cancer vaccine to be effective: [0039] a) The vaccine must contain antigens expressed by ...
EMULSIFIED COMPOSITION FOR DILUTION AND CANCER VACCINE COMPOSITION
Filed: January 19th, 2006 [Pending]
Patent Application Number: 11814270
2, in the group receiving the cancer vaccine composition of the present invention, the target cells pulsed with the peptide were severely injured, ...